This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
HIV, smoking, and the brain: a convergence of neurotoxicities
AIDS Research and Therapy Open Access 06 February 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nightingale, S. et al. Cognitive impairment in people living with HIV: consensus recommendations for a new approach. Nat. Rev. Neurol. 19, 424–433 (2023).
Matchanova, A., Woods, S. P. & Kordovski, V. M. Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults. J. Neurovirol. 26, 155–167 (2020).
Antinori, A. et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 1789–1799 (2007).
McIntosh, R. C. et al. The evolution of assessing central nervous system complications in human immunodeficiency virus: where do we go from here? J. Infect. Dis. 227 (Suppl 1), S30–S37 (2023).
Mohammadzadeh, N. et al. Lentiviral infections persist in brain despite effective antiretroviral therapy and neuroimmune activation. MBio 12, e0278421 (2021).
Suzuki, K. et al. Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury. Proc. Natl Acad. Sci. USA 119, e2210584119 (2022).
Angelovich, T. A. et al. Regional analysis of intact and defective HIV proviruses in the brain of viremic and virally suppressed people with HIV. Ann. Neurol. 94, 798–802 (2023).
Isherwood, S. J. S., Bazin, P. L., Alkemade, A. & Forstmann, B. U. Quantity and quality: normative open-access neuroimaging databases. PLoS ONE 16, e0248341 (2021).
Sheppard, D. P. et al. Elevated rates of mild cognitive impairment in HIV disease. J. Neurovirol. 21, 576–584 (2015).
Edmonds, E. C., Delano-Wood, L., Galasko, D. R., Salmon, D. P. & Bondi, M. W. Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease. J. Alzheimers Dis. 47, 231–242 (2015).
Acknowledgements
We thank people with lived experience of HIV and HAND who have shared their stories with us. We thank the community organizations who are working with us to address the needs of people living with HIV and HAND. We thank members of the NeuroHIV Aging and Advocy Group for their constructive discussion about cognitive health in people living and aging with HIV that have helped to inform the current Correspondence.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Cysique, L.A., Brew, B.J., Bruning, J. et al. Cognitive criteria in HIV: greater consensus is needed. Nat Rev Neurol 20, 127–128 (2024). https://doi.org/10.1038/s41582-024-00927-1
Published:
Issue date:
DOI: https://doi.org/10.1038/s41582-024-00927-1
This article is cited by
-
HIV, smoking, and the brain: a convergence of neurotoxicities
AIDS Research and Therapy (2025)
-
Associations Between Depressive Symptoms and Memory Functions in Persons with HIV: A Systematic Review and Meta-Analysis
Neuropsychology Review (2025)
-
Reply to ‘Cognitive criteria in HIV: greater consensus is needed’
Nature Reviews Neurology (2024)
-
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study
AIDS and Behavior (2024)